Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.18 is 74% below its 4-year average of 0.68, near the low end of its 4-year range (0.00–20.91).
As of the fiscal period ended Tuesday, June 30, 2026. 70.89% below its 12-month average of 0.60.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.18.
CURRENT RATIO
0.18
CURRENT RATIO AVG TTM
0.60
CURRENT RATIO AVG 3Y
0.69
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-70.89%
CURRENT VS 3Y AVG
-74.54%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 630 covered companies
CURRENT VS SECTOR MEDIAN
-94.76%
vs the sector median at left
Market Cap
$7.23M
Current Ratio
45.95
TTM Avg
58.73
3Y Avg
40.89
5Y Avg
40.89
Market Cap
$7.33M
Current Ratio
1.37
TTM Avg
4.18
3Y Avg
4.61
5Y Avg
4.18
Market Cap
$6.92M
Current Ratio
2.61
TTM Avg
3.40
3Y Avg
4.86
5Y Avg
5.09
Market Cap
$6.93M
Current Ratio
0.31
TTM Avg
1.26
3Y Avg
1.91
5Y Avg
5.47
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mangoceuticals, Inc. (MGRX) | $7.01M | 0.18 | 0.60 | 0.69 | N/A |
| Co-Diagnostics, Inc. (CODX)vs › | $7.07M | 1.81 | 4.14 | 10.76 | 11.50 |
| KALA BIO, Inc. (KALA)vs › | $7.22M | 6.88 | 3.46 | 4.15 | 4.60 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.23M | 45.95 | 58.73 | 40.89 | 40.89 |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.33M | 1.37 | 4.18 | 4.61 | 4.18 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.92M | 2.61 | 3.40 | 4.86 | 5.09 |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $6.93M | 0.31 | 1.26 | 1.91 | 5.47 |
| Longeveron Inc. (LGVN)vs › | $7.33M | 2.63 | 4.46 | 3.65 | 4.69 |
| Aclarion, Inc. (ACON)vs › | $6.70M | 16.20 | 7.76 | 4.60 | 3.08 |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.67M | 10.21 | 3.61 | 3.34 | 4.20 |
Current Ratio
0.18
Quick Ratio
0.18
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 0.18 |
| 2026-03-31 | 0.29 |
| 2025-12-31 | 1.74 |
| 2025-09-30 | 0.74 |
| 2025-06-30 | 0.07 |
| 2025-03-31 | 0.12 |
| 2024-12-31 | 0.05 |
| 2024-09-30 | 0.07 |
| 2024-06-30 | 0.38 |
| 2024-03-31 | 0.07 |
| 2023-12-31 | 3.88 |
| 2023-09-30 | 8.44 |
| 2023-06-30 | 15.39 |
| 2023-03-31 | 20.91 |
| 2022-12-31 | 2.67 |
| 2022-09-30 | 9.95 |
| 2022-06-30 | 0.01 |
| 2022-03-31 | 0.00 |
| 2021-12-31 | 0.00 |
